Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Abstract:
The investment was made by a syndicate of investors, including existing investor Mercia Technology Seed Fund, Advantage Enterprise & Innovation Fund (managed by Catapult Venture Managers) and a number of business angels.

Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Cambridge, UK | Posted on May 30th, 2011

Corporate finance solicitor Pippa Pearce led the Mills & Reeve team representing the highly innovative life sciences company, which develops and commercialises innovative magnetic nanoparticle based products in the gene therapy research market.

nanoTherics was spun out from Keele University in 2007 following 30 years of combined leading edge research into the use of magnetic nanoparticles for biomedical applications conducted at Keele University and the University of Florida.

The company provides unique scientific devices and associated reagents designed to significantly improve uptake of biomaterials into cells, a process referred to as transfection, to greatly facilitate research into gene-related diseases and disorders. The company's mission is to become the leading supplier of intellectual property protected magnetic nanoparticle-based devices and consumables for transfection, providing superior performance products addressing a global market and underpinning the research and development of current and future drug and genetic screening and gene therapy programmes.

The investment took place on two tranches, with the first tranche completing in August 2010 and the second in January 2011. Dr Linda Cammish, CEO of nanoTherics said: "The funding has come at the appropriate time to allow nanoTherics to further develop its innovative technologies and products and improve research into genetic disease disorders, from Alzheimer's to cancer. This investment represents a critical point in the company's growth strategy and will enable us to place additional resources into the commercialism of our products."

Dr Mark Payton, Fund Principal at Mercia added: "We're delighted to continue to support nanoTherics in the development of its scalable and disruptive products and look forward to the next exciting step in the company's growth plan." He went on to say: "Mills & Reeve's venture capital team provided vital support in helping us complete this round - their experience and expertise in advising on sometimes complex syndicated investments in early stage and developing high-tech businesses was invaluable."

Pippa Pearce was assisted on the transaction by corporate lawyers, Dona Ardeman and Danielle Gibson and technology solicitor Nicola Kenward. Pippa commented: "We are pleased to have been able to assist this ambitious technology company raise the finance needed to ramp up commercialisation of its exciting products. We will follow their progress with interest."

Advantage Enterprise & Innovation Fund were advised by West Midlands firm George Green, led by partner Guy Green and assisted by Philip Round.

####

About Cambridge Network
With offices located in Cambridge, Norwich, Birmingham, Leeds, Manchester and London, Mills & Reeve is one of the UK's largest law firms, offering the full range of corporate and commercial services.

Our Cambridge office includes a specialist IP team dedicated to advising the region's technology companies and we have a close working relationship with Trask Britt, a specialist intellectual property firm based in the US.

We have over 80 qualified lawyers operating from our Norwich and Cambridge offices; with 23 partners leading teams in commercial, tax, banking, corporate finance, pensions, disputes and regulatory matters, with a specific focus on technology-based companies, advising on IP/IT, environmental, health and safety and related property issues.

We were also selected as one of the top three firms by The Lawyer magazine's prestigious 'Law Firm of the Year Award', Mills & Reeve was listed in the Sunday Times '100 Best Companies to Work For' for the seventh year running.

For more information, please click here

Contacts:
Francis House, 112 Hills Road, Cambridge
Postcode: CB2 1PH
United Kingdom
Tel: 44 01223 364422
Fax: 44 01223 355848

www.mills-reeve.com/

Copyright © Cambridge Network

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Nanomedicine

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Announcements

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

Tools

Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026

From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026

Gap-controlled infrared absorption spectroscopy for analysis of molecular interfaces: Low-cost spectroscopic approach precisely analyzes interfacial molecular behavior using ATR-IR and advanced data analysis October 3rd, 2025

Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project